wedelolactone,
Wedelolactone,
524-12-9,
UNII-0K6L725GNS,
7-Methoxy-5,11,12-trihydroxycoumestan,
7-Methoxy-5,11,12-trihydroxy-coumestan,
1,8,9-Trihydroxy-3-methoxycoumestan,
Wedelolactone, Eclipta alba,
CHEMBL97453,
0K6L725GNS,
CHEBI:10037,
IKK Inhibitor II, Wedelolactone,
MFCD07778564,
1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one,
1,8,9-trihydroxy-3-methoxy-benzofuro[3,2-c]chromen-6-one,
1,8,9-Trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one,
IKK Inhibitor II,
AC1NQZ4Z,
SCHEMBL601220,
GTPL5551,
CTK8G3781,
DTXSID60200408,
Wedelolactone, analytical standard,
HMS2043P19,
BCP19859,
ZINC6483512,
BDBM50096619,
CM-842,
LMPK12090046,
AKOS015897173,
CCG-208289,
SMP2_000112,
5,11,12-Trihydroxy-7-methoxycoumestan,
NCGC00163667-01,
NCGC00163667-02,
NCGC00163667-03,
Wedelolactone, >=98% (HPLC), powder,
AN-45548,
SC-67595,
FT-0698529,
N2131,
A14804,
C10541,
K00058,
524W129,
SR-05000002318,
I07-0266,
SR-05000002318-2,
BRD-K53635676-001-01-5,
BRD-K53635676-001-02-3,
Wedelolactone; 7-Methoxy-5,11,12-trihydroxy-coumestan,
1,8,9-trihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one,
1,8,9-trihydroxy-3-methoxy-[1]benzoxolo[3,2-c]chromen-6-one,
1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c]chromen-6-one,
Wedelolactone, European Pharmacopoeia (EP) Reference Standard,
1,8,9-Trihydroxy-3-methoxy-benzo[4,5]furo[3,2-c]chromen-6-one,
6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy-,
6H-Benzofuro[3,2-c][1]benzopyran-6-one,1,8,9-trihydroxy-3-methoxy-,
D0F8QJ,
C16H10O7,
ACN-047038,
C16-H10-O7,
CID5281813,
C051122,
Wedelolactone, 98%, from Wedelia chinensis (Osbeck.) Merr. - 5MG 5mg,